作者
Moshe Lapidoth, Michael David, Dan Ben-Amitai, Varda Katzenelson, Shamir Lustig, Miriam Sandbank
发表日期
1994/5/1
期刊
Journal of the American Academy of Dermatology
卷号
30
期号
5
页码范围
752-757
出版商
Mosby
简介
Background: Cyclosporine, a potent immunosuppressive drug, has been suggested to be beneficial in the treatment of some immune-mediated dermatoses, including pemphigus.
Objective: The aim of the present study was to evaluate the efficacy and safety of combined treatment with prednisone and cyclosporine compared with prednisone alone in patients with pemphigus.
Methods: Sixteen hospitalized patients with pemphigus vulgaris received combined treatment with cyclosporine and prednisone for 12 months. Cyclosporine and prednisone were given orally at an initial dose of 5 mg/kg/day and 60 to 80 mg/day, respectively. The cyclosporine dose was adjusted to obtain plasma levels of 100 to 150 ng/L. A historical control group was composed of 15 patients with pemphigus who received prednisone at an initial dose of 120 mg/day, which was decreased according to clinical response. The clinical response …
引用总数
1995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320243544457678365663454332322322
学术搜索中的文章
M Lapidoth, M David, D Ben-Amitai, V Katzenelson… - Journal of the American Academy of Dermatology, 1994